South Korea · Delayed Price · Currency is KRW ENBIO Statistics
Total Valuation
ENBIO has a market cap or net worth of KRW 21.69 billion. The enterprise value is 38.61 billion.
| Market Cap | 21.69B |
| Enterprise Value | 38.61B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ENBIO has 10.87 million shares outstanding. The number of shares has decreased by -0.73% in one year.
| Current Share Class | 10.87M |
| Shares Outstanding | 10.87M |
| Shares Change (YoY) | -0.73% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 9.59% |
| Owned by Institutions (%) | n/a |
| Float | 9.83M |
Valuation Ratios
The trailing PE ratio is 27.19.
| PE Ratio | 27.19 |
| Forward PE | n/a |
| PS Ratio | 0.63 |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 3.97 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 48.41 |
| EV / Sales | 1.13 |
| EV / EBITDA | 15.42 |
| EV / EBIT | 43.27 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.43.
| Current Ratio | 2.09 |
| Quick Ratio | 0.11 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 7.64 |
| Debt / FCF | -23.79 |
| Interest Coverage | 1.47 |
Financial Efficiency
Return on equity (ROE) is 1.81% and return on invested capital (ROIC) is 1.40%.
| Return on Equity (ROE) | 1.81% |
| Return on Assets (ROA) | 0.75% |
| Return on Invested Capital (ROIC) | 1.40% |
| Return on Capital Employed (ROCE) | 1.65% |
| Weighted Average Cost of Capital (WACC) | 5.43% |
| Revenue Per Employee | 428.29M |
| Profits Per Employee | 9.97M |
| Employee Count | 80 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 1.28 |
Taxes
In the past 12 months, ENBIO has paid 102.65 million in taxes.
| Income Tax | 102.65M |
| Effective Tax Rate | 11.40% |
Stock Price Statistics
The stock price has decreased by -23.67% in the last 52 weeks. The beta is 0.64, so ENBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -23.67% |
| 50-Day Moving Average | 2,223.30 |
| 200-Day Moving Average | 2,199.16 |
| Relative Strength Index (RSI) | 30.79 |
| Average Volume (20 Days) | 24,111 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ENBIO had revenue of KRW 34.26 billion and earned 797.61 million in profits. Earnings per share was 73.42.
| Revenue | 34.26B |
| Gross Profit | 11.65B |
| Operating Income | 892.30M |
| Pretax Income | 900.26M |
| Net Income | 797.61M |
| EBITDA | 2.50B |
| EBIT | 892.30M |
| Earnings Per Share (EPS) | 73.42 |
Balance Sheet
The company has 2.22 billion in cash and 19.15 billion in debt, with a net cash position of -16.92 billion or -1,557.07 per share.
| Cash & Cash Equivalents | 2.22B |
| Total Debt | 19.15B |
| Net Cash | -16.92B |
| Net Cash Per Share | -1,557.07 |
| Equity (Book Value) | 44.56B |
| Book Value Per Share | 4,100.81 |
| Working Capital | 22.02B |
Cash Flow
In the last 12 months, operating cash flow was 5.46 billion and capital expenditures -6.27 billion, giving a free cash flow of -804.71 million.
| Operating Cash Flow | 5.46B |
| Capital Expenditures | -6.27B |
| Depreciation & Amortization | 1.61B |
| Net Borrowing | -640.21M |
| Free Cash Flow | -804.71M |
| FCF Per Share | -74.05 |
Margins
Gross margin is 33.99%, with operating and profit margins of 2.60% and 2.33%.
| Gross Margin | 33.99% |
| Operating Margin | 2.60% |
| Pretax Margin | 2.63% |
| Profit Margin | 2.33% |
| EBITDA Margin | 7.31% |
| EBIT Margin | 2.60% |
| FCF Margin | n/a |
Dividends & Yields
ENBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.73% |
| Shareholder Yield | 0.73% |
| Earnings Yield | 3.68% |
| FCF Yield | -3.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ENBIO has an Altman Z-Score of 1.21 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.21 |
| Piotroski F-Score | 7 |